ALMIRALL, S.A. The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 25/06/2019 07:14 ALMIRALL, S.A. R&D: new licenses, patents and registered trademarks. - Announcements of public presentations and meetings Conference call with analysts and institutional investors: Presentation of License Agreement of lebrikizumab for Atopic Dermatitis in Europe Register number: 279523